Oil rises after surprise drop in US inventories offsets demand concernsU.S. oil gained 14 cents, or 0.3%, to $41.18 a barrel, having dropped 1.4% in the previous session.
Oil prices slip on demand fears as US virus cases surge"Counter-seasonal builds in gasoline inventories as stockpiles unexpectedly rose are not precisely a bullish delight," AxiCorp strategist S...
Oil prices drop as rising US coronavirus cases stoke fears of weak fuel demand"Concerns about the recent uptick in COVID-19 infections in the US and a potential 'second wave' are weighing on oil at the moment," said S...
Oil drops after US inventory build renews oversupply concernsWest Texas Intermediate (WTI) futures declined 68 cents, or 1.8%, to $38.26 a barrel, having risen about 2% in the previous session.
Gold inches higher, moves in tight range ahead of US Fed meeting"Given the enthusiasm for risk and growth exposed assets, we could see pressure come to gold during the session, but on the other hand the ...
Oil falls as US-China tensions take tollBoth contracts have risen for the past four weeks, although prices are still down around 45% so far this year.
Beijing may base security agencies in Hong KongHong Kong leader Carrie Lam said her government will “fully cooperate” with the Chinese parliament to complete the legislation, which she s...
Oil gains on hopes that easing of coronavirus curbs will trigger demand boostU.S. oil gained 48 cents, or 1.5%, to $24.03 a barrel, after a decline of nearly 2% in the previous session.
Oil prices recover ground after market turmoil fuels price plungeWest Texas Intermediate was up $2.05, or 18%, at $13.62 a barrel by 0034 GMT.
Gold falls as dollar firms, shares rally; set to post quarterly gainUS gold futures eased 0.2 per cent to $1,615.50.
Dow futures tank 1.4% as coronavirus risks deepenBenchmark 10-year US Treasuries fell to record lows, while gold rose 0.5%. Oil prices slid to their lowest in more than a year on fears of ...
- Biocon Q1 net dips 8.8% to Rs 70 crore; Axicorp absence weighs
In the comparative period last year, Axicorp, which Biocon exited in April, contributed 12 crore to the net profit.
Will definitely deliver double-digit growth in FY12: Kiran Mazumdar Shaw, BioconIn a chat with ET Now, Kiran Mazumdar Shaw, Chairperson and Managing Director, Biocon, talks about the company's growth prospects and expec...
- Biocon picks up 70% in German pharma co AxiCorp for e30 mn
The deal will enable the Bangalore-based player to market its injectible insulin, generics, biosimilars and biologics in Europe.
- Satyam gains over three pc on BSE
Even as the Indian stock market sank 834 points, its third biggest fall in absolute terms, IT services provider Satyam Computer Services to...
- Biocon acquires German co for euro 30 mn
Biocon will acquire 70 per cent stake in German pharmaceutical AxiCorp GmbH for euro 30 million.
- Biocon buys 70 pc of Germany's AxiCorp
Biotechnology firm Biocon on Monday announced the acquisition of a 70 per cent stake in German pharmaceutical company, AxiCorp GmbH, for Eu...